Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases

By Conant Katherine   Hillaire Coryse   Anderson Caroline   Galey David   Wang Jessica   Nath Avindra  

Journal of NeuroVirology, Vol. 10, Iss. 1, 2004-02 ,pp. : 21-28

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Molecular mechanism(s) involved in the synergistic induction of CXCL10 by human immunodeficiency virus type 1 Tat and interferon-γ in macrophages

By Dhillon Navneet   Zhu Xuhui   Peng Fuwang   Yao Honghong   Williams Rachel   Callen Shannon   Ladner Amy O'Brien   Buch Shilpa   Qiu Jianming  

Journal of NeuroVirology, Vol. 14, Iss. 3, 2008-05 ,pp. : 196-204

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Proteomic analyses of monocyte-derived macrophages infected with human immunodeficiency virus type 1 primary isolates from Hispanic women with and without cognitive impairment

By Toro-Nieves Dm   Rodriguez Y.   Plaud M.   Ciborowski P.   Duan F.   Laspiur J Perez   Wojna V.   Melendez LM  

Journal of NeuroVirology, Vol. 15, Iss. 1, 2008-12 ,pp. : 36-50

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

By Schifitto Giovanni   Zhong Jianhui   Gill David   Peterson Derick   Gaugh Michelle   Zhu Tong   Tivarus Madalina   Cruttenden Kim   Maggirwar Sanjay   Gendelman Howard   Dewhurst Stephen   Gelbard Harris  

Journal of NeuroVirology, Vol. 15, Iss. 2, 2009-04 ,pp. : 176-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains

By Kumar Adarsh   Fernandez JB   Singer Elyse   Commins Deborah   Waldrop-Valverde Drenna   Ownby Raymond   Kumar Mahendra  

Journal of NeuroVirology, Vol. 15, Iss. 3, 2009-06 ,pp. : 257-274

Ashgate Publishing Ltd

Access to resources Recommend Favorite